Fate Therapeutics (FATE) Other Non-Current Assets (2012 - 2026)

Fate Therapeutics has reported Other Non-Current Assets for 15 years, with the latest figure at $10.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at $10.0 million (changed N/A YoY), and the FY2025 full-year result was $10.2 million, up 113533.33% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $10.0 million, down from $10.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $15.2 million in Q1 2022, with the low at $9000.0 in Q3 2023.
• Historically, Other Non-Current Assets has averaged $8.0 million across 5 years, with a median of $10.1 million in 2025.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 169088.89% — and 2023, when it slumped 99.94%.
• Fate Therapeutics' Other Non-Current Assets stood at $15.2 million in 2022, then fell by 0.33% to $15.2 million in 2023, then tumbled by 99.94% to $9000.0 in 2024, then soared by 113533.33% to $10.2 million in 2025, then dropped by 1.73% to $10.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $10.0 million (Q1 2026), $10.2 million (Q4 2025), and $9000.0 (Q4 2024), per Business Quant data.